drugset
drugset / Trial / NCT00469781

Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening

NCT00469781 ↗

Phase 4 Completed 95 enrolled Center For Excellence In Eye Care
RandomizedParallel-groupSingle-blindPrevention

Summary

The objective of this study is to determine if twice-daily dosing of prednisolone (Pred Forte) is as effective as four-times-daily dosing of prednisolone for the prevention of retinal thickening and cystoid macular edema (CME) when either regimen is used concomitantly with twice-daily bromfenac.

Timeline

Start
2007-05
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisolone Other / unclassified — Other
Background Bromfenac Other / unclassified — Other

Indications

cystoid macular edema